NOVT N Stock Overview
Provides precision medicine and manufacturing, medical solutions, and robotics and automation solutions in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Novanta Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$2,640.93 |
| 52 Week High | US$2,879.44 |
| 52 Week Low | US$2,640.93 |
| Beta | 1.33 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | -2.55% |
| 5 Year Change | 57.81% |
| Change since IPO | 61.02% |
Recent News & Updates
Recent updates
Shareholder Returns
| NOVT N | MX Electronic | MX Market | |
|---|---|---|---|
| 7D | 0% | 0% | 0% |
| 1Y | n/a | 0% | 0% |
Return vs Industry: Insufficient data to determine how NOVT N performed against the MX Electronic industry.
Return vs Market: Insufficient data to determine how NOVT N performed against the MX Market.
Price Volatility
| NOVT N volatility | |
|---|---|
| NOVT N Average Weekly Movement | n/a |
| Electronic Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in MX Market | 0% |
| 10% least volatile stocks in MX Market | 0% |
Stable Share Price: NOVT N has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine NOVT N's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1968 | 2,900 | Matthijs Glastra | www.novanta.com |
Novanta Inc., together with its subsidiaries, provides precision medicine and manufacturing, medical solutions, and robotics and automation solutions in the United States and internationally. The company operates through three segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation. The Precision Medicine and Manufacturing segment offers photonics-based solutions, including laser scanning, beam delivery, CO2 laser, solid state laser, ultrafast laser, and optical light engine products serving photonics-based applications for industrial processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures.
Novanta Inc. Fundamentals Summary
| NOVT N fundamental statistics | |
|---|---|
| Market cap | Mex$100.40b |
| Earnings (TTM) | Mex$1.20b |
| Revenue (TTM) | Mex$14.47b |
84.0x
P/E Ratio6.9x
P/S RatioIs NOVT N overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NOVT N income statement (TTM) | |
|---|---|
| Revenue | US$881.66m |
| Cost of Revenue | US$486.77m |
| Gross Profit | US$394.90m |
| Other Expenses | US$322.02m |
| Earnings | US$72.88m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 07, 2024
| Earnings per share (EPS) | 2.03 |
| Gross Margin | 44.79% |
| Net Profit Margin | 8.27% |
| Debt/Equity Ratio | 52.6% |
How did NOVT N perform over the long term?
See historical performance and comparison